NEXR
Nexera Technologies Ltd
NASDAQ · Healthcare · Biotechnology · IL
$1.71
+4.27%Margins
Gross margin
11.4%
EBITDA margin
-32.3%
EBIT margin
-38.9%
Net margin
-26.9%
FCF margin
-36.0%
-129.2%
Return on equity
-82.2%
Return on assets
-158.0%
Return on invested capital
1.36x
Asset turnover
-$8.7M
Cash from operations
$1.40
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026